Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T04:06:28.776Z Has data issue: false hasContentIssue false
  • English
  • Français

Comparison in the immunological properties of Borrelia burgdorferi isolates from Ixodes ricinus derived from three endemic areas in Switzerland

Published online by Cambridge University Press:  15 May 2009

C. M. Hu ,
S. Leuba-Garcia ,
M. D. Kramer ,
A. Aeschlimann  and
L. Gern
C. M. Hu
Affiliation:
Institut de Zoologie, Neuchâtel University, CH-2000 Neuchâtel, Switzerland
S. Leuba-Garcia
Affiliation:
Institut de Zoologie, Neuchâtel University, CH-2000 Neuchâtel, Switzerland
M. D. Kramer
Affiliation:
Institut für Immunologie, Ruprecht-Karls-Universität, Heidelberg, Germany
A. Aeschlimann
Affiliation:
Institut de Zoologie, Neuchâtel University, CH-2000 Neuchâtel, Switzerland
L. Gern*
Affiliation:
Institut de Zoologie, Neuchâtel University, CH-2000 Neuchâtel, Switzerland
*
* Author for correspondence: Institut de Zoologie, Chantemerle 22, CH-2000 Neuchâtel, Switzerland.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Borrelia burgdorferi isolates were obtained from Ixodes ricinus from three sites in Switzerland. They were examined by SDS-PAGE and immunoblotting. The phenotypes, in respect of three outer surface proteins (Osp), differed between the sites of collection. In site 1, most isolates had an OspA of 31 kDa and an OspB of 34 kDa: in site 2, isolates presenting an OspA of 33 kDa dominated and in site 3, the isolates with an OspA of 32 kDa and an OspB of 35 kDa were most frequent. This distribution differed significantly. About half of the isolates from sites 1 and 3 reacted with anti-OspA monoclonal antibody H5332 compared to 29% from site 2. Site 1 isolates reacted significantly more frequently (81 %) with another anti-OspA monoclonal antibody LA-31 than isolates from site 3 (P < 0·0001). These findings have implications for the epidemiology of Lyme borreliosis, for the further development of serodiagnostic reagents and for the development of a vaccine.

Type
Research Article
Information
Epidemiology & Infection , Volume 112 , Issue 3 , June 1994 , pp. 533 - 542
Copyright
Copyright © Cambridge University Press 1994

References

REFERENCES

1.Steere, AC, Bartenhagen, NH, Craft, JE et al. Clinical manifestations of Lyme disease. Zentralblatt für Bakteriologie, Mikrobiol Hyg 1986; A263: 201–5.Google Scholar
2.Burgdorfer, W. Discovery of the Lyme disease spirochete and its relation to tick vectors. Yale J Biol Med 1984: 57: 515–20.Google ScholarPubMed
3.Barbour, AG, Tessier, SL, Todd, WJ. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody. Infect Immun 1983: 41: 795–804.CrossRefGoogle Scholar
4.Barbour, AG, Tessier, SL, Hayes, SF. Variation in a major surface protein of Lyme disease spirochete. Infect Immun 1984: 45: 94–100.CrossRefGoogle Scholar
5.Wilske, B, Preac-Mursic, V, von Busch, K. Immunochemical and immunological analysis of European Borrelia burgdorferi strains. Zentralblatt Bakteriol Hyg 1986; 263: 92–102.Google ScholarPubMed
6.Fuchs, R, Jauris, S, Lottspeich, F, Preac-Mursic, V, Wilske, B, Soutschek, E. Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli. Molec Microbiol 1992; 6: 503–9.CrossRefGoogle ScholarPubMed
7.Barbour, AG, Garon, CF. Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science 1987; 237: 409–11.CrossRefGoogle ScholarPubMed
8.Barbour, AG, Heiland, RA, Tessin, HR. Heterogeneity of major protein in Lyme disease borrelia: a molecular analysis of American and European isolates. J Infect Dis 1985; 152: 478–84.CrossRefGoogle ScholarPubMed
9.Wilske, B, Preac-Mursic, V, Schierz, G, Kühbeck, R, Barbour, AG, Kramer, MD. Antigenic variability of Borrelia burgdorferi. Annals NY Acad Sci 1988; 593: 126–43.CrossRefGoogle Scholar
10.Rosa, PA, Hogan, DM. Colony formation by Borrelia burgdorferi in solid medium clonal: analysis of Osp locus variants. First International Conference on Tick-Borne Pathogens at the Host–Vector Interface: An Agenda for Research. Saint Paul, Minnesota, USA. 1992; 95–103.Google Scholar
11.Péter, O, Bretz, AG. Polymorphism of outer surface proteins of Borrelia burgdorferi as a tool for classification. Zentralblatt Bakteriol 1992; 277: 28–33.CrossRefGoogle ScholarPubMed
12.Wallich, R, Moter, SE, Kramer, MD et al. , Untersuchungen zur genotypischen und phänotypischen Heterogenität von Borrelia burgdorferi, dem Erreger der Lyme-Borreliose Infection. In: Hassler, D, Kramer, M, Maiwald, M, Marget, W, Zöller, L, eds. Forschritte der Infektiologie. München: MMV Verlag 1992: 176–91.Google Scholar
13.Barbour, AG. Isolation and cultivation of Lyme disease spirochete. Yale J Biol Med 1984: 57: 521–5.Google Scholar
14.Hu, CM, Gern, L, Aeschlimann, A. Changes in the protein profile and antigenicity of different Borrelia burgdorferi strains after reintroduction to Ixodes ricinus. Parasite Immunol 1992: 14: 415–27.CrossRefGoogle ScholarPubMed
15.Kramer, MD, Schaible, UE, Wallich, R, Moter, SE, Petzoldt, D, Simon, MM. Characterization of Borrelia burgdorferi associated antigens bv monoclonal antibodies. Immunobiol 1990: 181: 357–66.CrossRefGoogle Scholar
16.Kirk, R. Experimental design. Procedure for behavioral sciences. Belmont, California: Brooks, 1968.Google Scholar
17.Wilske, B, Preac-Mursic, V, Schierz, G, Liegl, G, Gueye, W. Detection of IgM and IgG antibodies to Borrelia burgdorferi using different strains as antigen. Zentralblatt Bakteriol, Mikrobiol Hyg 1989; Suppl. 18: 299–309.Google Scholar
18.Ma, B, Christen, B, Leung, D, Vigo-Pelfrey, C. Serodiagnosis of Lyme Borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol 1992; 30: 370–6.CrossRefGoogle ScholarPubMed
19.Gern, L, Schaible, UE, Simon, MM. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis 1993; 167: 971–5.CrossRefGoogle ScholarPubMed
20.van Dam, AP, Kuiper, H, Vos, K et al. , Different genospecies of Borrelia burgdorferi are associated with clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993: 17: 708–17.CrossRefGoogle ScholarPubMed
21.Schaible, UE, Kramer, MD, Eichmann, K, Modolell, M, Museteanu, C, Simon, MM. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc Nat Acad Sci USA 1990: 87: 3768–72.CrossRefGoogle ScholarPubMed
22.Gern, L, Frossard, E, Walter, A, Aeschlimann, A. Presence of antibodies against Borrelia burgdorferi in a population of the Swiss Plateau. Zentralblatt Bakteriol, Mikrobiol Hyg 1989; Suppl. 18: 321–8.Google Scholar
23.Gern, L, Garcia, S, Frossard, E. Characterization and follow-up the IgG antibody response against Borrelia burgdorferi using Western blot in a seropositive (ELLSA) population from an endemic area. Bull Soc Neuchâteloise Sciences Naturelles 1993; 116: 5–14.Google Scholar
24.Fikrig, R, Barthold, SW, Kantor, FS, Flavell, RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 1990; 250: 553–6.CrossRefGoogle ScholarPubMed
25.Fikrig, R, Barthold, SW, Kantor, FS, Flavell, RA. Long term protection of mice from Lyme disease by vaccination with OspA. Infect Immun 1992; 60: 773–7.CrossRefGoogle ScholarPubMed
26.Simon, MM, Schaible, UE, Kramer, MD et al. , Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice. J Infect Dis 1991; 164: 123–32.CrossRefGoogle ScholarPubMed